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Abstract
The aim of the study was an evaluation of the effects of a 12-week physical training programme on the levels of bone turnover markers 
[Sclerostin, Osteocalcin (OC), C-terminal telopeptide of type I collagen (b-CTX)] in serum of women with osteopenia. 
Materials and methods: The study included 50 women at the age of 50–75 years with the diagnosis of osteopenia. During the initial 
12 weeks (between point 1 and 2), the patients maintained their previous, normal level of physical activity. During subsequent 12 weeks 
(between point 2 and 3), a programme of exercise was implemented. The programme included the interval training on a bicycle ergom-
eter, three times a week for 36 minutes. During the entire study duration, all the patients received a supplementation of calcium (500 mg) 
and vit. D3 (1800 IU) once daily. Serum levels of OC, alkaline phosphatase (ALP), b-CTX and sclerostin were assayed at 3 time points.
Results: After the course of the exercise cycle, the OC concentration was increased, sclerostin levels decreased, while no statistical differ-
ences were observed in b-CTX levels vs. the period of physical inactivity. No correlations were found between sclerostin level changes 
and osteocalcin level changes during the training time, probably because of too small groups. Neither statistically significant were the 
differences in alkaline phosphatase, calcium and phosphorus levels. 
Conclusions: The obtained results emphasise the role of physical training as an effective stimulation method of bone formation processes 
in women with osteopenia. Sclerostin can be a marker of physical activity. (Endokrynol Pol 2018; 69 (2): 142–149)
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Streszczenie
 Celem pracy była ocena wpływu 12-tygodniowego treningu ruchowego na stężenie markerów obrotu kostnego [Sklerostyny, Osteokal-
cyny (OC), C-końcowego telopeptydu kolagenu typu I (b-CTX)] w surowicy krwi pacjentek z osteopenią.
Materiał i metody: Do badania zostało włączonych 50 pacjentek, w wieku 50–75 lat z rozpoznaniem osteopenii. Przez pierwsze 12 tygodni 
(punkt 1 i 2) pacjentki prowadziły dotychczasowy poziom aktywności fizycznej. Przez kolejne 12 tygodni (między punktem 2 i 3) został 
włączony program ćwiczeń fizycznych. Program obejmował trening interwałowy, przeprowadzony na cykloergometrze rowerowym 
3 razy w tygodniu, po 36 minut. Wszystkie pacjentki przez cały okres trwania badania pozostawały na suplementacji 500 mg wapnia i 
1800 j.m. witaminy D3 dziennie. W surowicy krwi w 3 punktach czasowych oznaczano OC, fosfatazę zasadową (ALP), b-CTX oraz skle-
rostynę. 
Wyniki: Po cyklu treningu fizycznego uzyskano wzrost stężenia OC, spadek sklerostyny, natomiast nie odnotowano istotnych statystycz-
nie różnic w poziomie markera b-CTX w porównaniu do okresu bez ćwiczeń. Nie wykazano korelacji pomiędzy zmianami sklerostyny 
a zmianami osteokalcyny w czasie treningu, prawdopodobnie ze względu na liczebność grup. Różnice w poziomach fosfatazy zasadowej, 
wapnia i fosforu również nie były istotne statystycznie. 
Wnioski: Wyniki badania podkreślają rolę treningu fizycznego, jako skutecznej metody pobudzania procesów kościotworzenia u pacjentek 
z osteopenią. Sklerostyna może być markerem aktywności ruchowej. (Endokrynol Pol 2018; 69 (2): 142–149)
Słowa kluczowe: aktywność fizyczna, trening, sklerostyna, markery
Introduction
Mechanical loads, imposed on bones, induce the 
activation of osteocytes which make 90–95% of the 
cell component in adult skeleton [1, 2]. Osteocytes 
effectively identify mechanical signals, being located 
at small cavities, called lacunas, in the mineralised 
bone matrix. While transmitting signals to other cells, 
osteocytes initiate bone tissue rebuilding process [3, 4]. 
The mechanism, by which mechanical energy is 
transformed into electric stimuli, with subsequent bio-
chemical responses, is called mechanotransduction and 
plays a key role in the process of skeleton adaptation to 
actual mechanical loads [5]. 
Biochemical markers of bone turnover that reflect 
the cellular activity related to the bone formation and 
bone resorption can be useful in understanding the ef-
fects of physical activity on bone [6]. However, many of 
these markers demonstrate certain limitations, includ-
ing the lack of specificity towards the osseous tissue, 
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an inability to identify metabolic activities of various 
bone elements. It should also be considered that these 
markers reflect mainly the function of osteoclasts and 
osteoblasts, and not the activity of osteocytes, while it 
is osteocytes which play the key role in maintaining 
skeleton integrity. Responding to these limitations, 
the latest studies on bone metabolism markers pay 
a special attention to sclerostin — the protein produced 
by osteocytes [7, 8].
Sclerostin is being almost exclusively produced by 
osteocytes. It inhibits the transfer of signals towards ac-
tivation, proliferation and differentiation of osteoblasts 
from mesenchymal cells. In case of bone lesions, osteo-
cytes suppress sclerostin secretion in order to activate 
the processes of osteogenesis and bone repair [9]. Scle-
rostin overexpression in bone induces osteopenia [10]. 
Sclerostin stimulates the apoptosis of osteoblasts, thus 
providing a potential mechanism by which it may 
inhibit osteogenesis [10, 11]. A bone, which is not ex-
posed to mechanical loads, faces the risk of sclerostin 
concentration increase and, in consequence, a higher 
incidence rate of osteocyte apoptosis, what enhances 
the recruitment of osteoclasts and thus bone resorp-
tion and loss processes [12]. Immobilisation and lack 
of physical activity may stimulate the synthesis of this 
protein [13]. Sclerostin is an inhibitor of the intracellular 
Wnt signalling pathway [9, 14]. The signalling via the 
Wnt pathway is a critical point for bone strength, as it 
stimulates the differentiation process of cells towards 
osteoblasts and bone tissue formation, while also sup-
pressing resorption processes. Deactivation of sclerostin 
activity on the Wnt/b-catenin signalling pathway is 
tantamount to the anabolic effect and thus — to the 
prevalence of osteogenic mechanisms [9, 15]. 
Osteocalcin (OC) is one of the markers of osteogen-
esis. OC is produced by mature osteoblasts, but some of 
circulating OC is released to circulation by osteoclasts 
[16]. OC concentration reflects the intensity of osteogen-
esis and is positively correlated with the histomorpho-
metric parameters of the bone formation process [17]. 
Physical activity imposes mechanical loads on bone 
tissue by the combined effect of external forces and 
muscular contractions which exert a higher impact 
on bones than other, gravitation-related forces [18]. 
However, some conditions are to be met in order to 
make physical conditions a source of positive effects 
for the bone system. The effectiveness of physical 
training in the prophylactics of osteoporosis depends, 
among others, on the intensity of physical exercises, 
the intervals between repetitions of the same exercise 
and of particular exercising sessions [19]. Thus a need 
emerges to design an appropriate training programme 
to be oriented onto the effective stimulation of osteo-
genic processes.
Study goals
The primary goal of the study was an evaluation of 
the effects of a 12-week interval training programme 
on sclerostin protein concentrations in serum, together 
with an assessment of the training influence on the 
concentration of bone metabolism markers: OC and 
C-terminal Telopeptide type 1 Collagen (b-CTX) in 
serum in female patients with low bone mass. Another 
(secondary) goal of the study was an evaluation of the 
relationships between sclerostin and OC concentra-
tions and BMD. 
Materials and methods
The study was carried out between January 2012 and 
December 2014. Physical activity trainings and blood 
collections were performed between September and 
April periods.
The participants included 50 female patients. Their 
age was varying between 50 and 75 years (see Table 
I). Inclusion criteria: female gender, clinical diagnosis 
— osteopenia (following the guidelines of the World 
Health Organisation for T-Score from –1.0 to –2.5 SD 
in proximal femur and/or lumbar spine densitometry); 
low or moderate physical activity, assessed by IPAQ 
— International Physical Activity Questionnaire [20]. 
Exclusion criteria: male gender; concomitant diseases 
(active inflammatory diseases, psychic diseases, im-
paired functionality of a motor organ, precluding any 
possibility to carry out a physiotherapy programme, 
BMD-affecting diseases); intake of bone metabolism 
affecting drugs, including, among others: bisphospho-
nates, strontium ranelate, glucocorticoids; disqualifica-
tion by exercise test results.
The study lasted 24 weeks. During the first 12 weeks, 
the patients remained at the previous level of physical 
activity (between the 1st and the 2nd time point). Dur-
ing the other 12 weeks, a cardio workout programme 
was introduced (between the 2nd and the 3rd time 
point (see Figure 1).
Before the study, all the patients were submitted to 
an exercise test at the Department of Sports Medicine. 
Out of the fifty qualified patients, the study project 
was completed by 41 women (82%). The causes of 
withdrawal included: motor organ pains during the 
exercise programme (n = 2), disease (n = 4), personal 
(n = 3). During the entire study duration, all the pa-
tients received a supplementation programme, includ-
ing calcium (500 mg) and vit. D3 (1800 IU) once daily.
Biochemical studies
Blood sampling was carried out fasting at 9:00 am to 
minimize circadian effects. Blood samples after the 
12-weeks of interval physical training on a bicycle 
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ergometer were collected next day after the last train-
ing session. 
Biochemical assays, including bone turnover marker 
concentrations, employed the following methods and kits: 
 — Alkaline Phosphatase — by the colorimetric method, 
supported by Olympus kits and analyser (of Olym-
pus Life and Material Sciences, Ireland), at wave 
lengths of 410 and 480 nm, following the manufac-
turer’s recommendations. 
 — Osteocalcin (OC) and b-CrossLaps (b-CTX) by the 
electrochemiluminescence method, using an Elecsys 
2010 analyser (Roche Diagnostics) and kits of Roche 
Diagnostics (Penzberg, Germany), following the 
manufacturer’s recommendations. 
 — Sclerostin by the ELISA Enzyme-Linked Immu-
nosorbent Assay) with kits of Biomedica Gruppe 
(Vienna, Austria) and a Metertech e960 spectropho-
tometer (Metertech Inc., Taiwan). The assays were 
carried out at wavelengths of 450 nm, using a refer-
ence filter of 620 nm, following the instructions of 
the Elisa’s manufacturer. The intra- and inter-assay 
coefficients of variation (CVs) were ≤ 7% and ≤ 10% 
and the limit of detection was 0.07 ng/ml. 
 — Total calcium in serum — by quantitative colori-
metric assay at wavelengths of 660 and 700 nm, 
using kits of Beckman Coulter (Beckman Coulter 
Inc., USA) and an Olympus analyser (Olympus 
Life and Material Sciences, Ireland), following the 
manufacturer’s recommendations. 
 — Inorganic phosphorus content in serum, by the pho-
tometric method, at wavelengths of 340 and 380 nm, 
using kits and an analyser of Olympus (Olympus 
Life and Material Sciences, Ireland), according to 
the manufacturer’s protocol. 
 — Total vitamin D (25 hydroxyvitamin D3 and 25 
hydroxyvitamin D2) by the electrochemilumi-
nescence method, using an Elecsys 2010 analyser 
(Roche Diagnostics) and kits of Roche Diagnostics 
(Penzberg, Germany), following the manufacturer’s 
recommendations. 
 — The serum, used for sclerostin, b-CTX and OC as-
says, was frozen immediately after centrifuging and 
stored in temperature of –70°C until assayed. The 
other laboratory tests, i.e., serum calcium and phos-
phate levels, as well as the concentration of alkaline 
phosphatase, were measured on an ongoing basis 
in the morning and in fasting condition. 
Densitometric examination
Bone mineral density studies were carried out by the 
dual-energy x-ray absorptiometry (DXA) method, using 
a GE Lunar Prodigy device. The minimum acceptable 
precision for technologists in our facility does not ex-
ceed the values: 1.9% (LSC = 5.3%) for Lumbar Spine, 
1.8% (LSC = 5.0%) for Total Hip and 2% (LSC = 5.5%) 
for Femoral Neck. 
Motor activity program
The biochemical tests were repeated after 12 weeks from 
the initial studies, using the same testing tools. Then, 
the patients, qualified to the programme, began the 
12-week training of physical activity. It was an interval 
training, performed on a MONARK 915E testing bike 
ergometer. Training sessions were held three times 
a week. Each session lasted 36 minutes and consisted 
of 5 stages, preceded by a 4-minute warming-up (the 
total exercise time, including the warming-up, was 
40 minutes). The training method was based on patient’s 
4-minute exercise, followed by a 2-minute rest phase. 
Table I. General characteristics of study population
Tabela I. Ogólna charakterystyka populacji badanej 
Feature
Studied group (n = 50)
Mean SD
Age (years) 64.8  5
BMI [kg/sq.m.] 26.1 3.46
WHR 0.8 0.07
T-Score
— lumbar spine (L2-L4)
— neck femur
–2.04
–1.95
0.69
0.32
BMD (g/cm2)
— lumbar spine (L2-L4)
— neck femur
0.9
0.78
0.28
0.07
Ca [mmol/l] 2.43 0.12
P [mmol/l] 1.14 0.13
ALP [U/l] 75.24 14.85
Vitamin D3 [ng/ml] 23.7 11.96
SD — standard deviation, Ca — calcium content in serum, P — phosphate 
content in serum, ALP — alkaline phosphatase
Figure 1. Study schema — 1. Inclusion into study — baseline; 
2. After 12 weeks of observation. Time point when physical activity 
was started; 3. After 12 weeks of physical activity
Rycina 1. Schemat badania — 1. Włączenie do badania — 
początek; 2. Po 12 tygodniach obserwacji. Moment rozpoczęcia 
programu aktywności fizycznej 3. Po 12 tygodniach aktywności 
fizycznej
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All patients were performed stress test in order to quali-
fy to participate in the study, as well as to determine the 
exercise intensity. On the basis of this test, all patients 
started from the same level of load (measured in Watts), 
according to the following scheme: warm-up (30 Watts) 
— a two-minute break — exercise (45 Watts) —a two-
minute break — exercise (60 Watts) — two-minute break 
— exercise (45 Watts) — two-minute break — exercise 
(30 Watts) — end with no load. All participants started 
with the same maximum load that was 60 Watts. In case 
of patients that were obtaining a better physical fitness 
during the training, (reduction of heart rate during 
exercise in comparison to baseline) physical load was 
being increased by 25 Watts at every stage of training. 
After completion of the study patients achieved the 
following maximum loads: 75 Watts — 16 patients; 
90 Watts — 17 patients. In case of 7 patients the maxi-
mum load remained unchanged. The entire training 
period was continuously monitored by ECG and the 
arterial pressure was measured each six-minute period 
by the sphygmomanometric method on the left arm.
Statistical analysis
Distributions of variables at given time points and their 
conformity with normal distribution were examined in 
the first stage of analysis. The normality Shapiro-Wilk 
test was applied to verify the hypothesis of the nor-
mality of distributions of particular variables. In cases, 
where there were no grounds to refuse the hypothesis 
that a given distribution is conformable with the normal 
distribution, the ANOVA test was applied with repeated 
measurements. While in case of any incompatibility of 
distribution with the normal distribution, the Friedman 
ANOVA test was used (or the Wilcoxon pair sequence 
test in case when two points were compared).
Results
Results of physical activity level evaluation 
All the patients were qualified on the basis of a ques-
tionnaire to a group, demonstrating a moderate level 
of physical activity. 
Based on the analysed data, significant differences 
were observed between vitamin D3 concentrations 
before and after the study (see Table II). Significantly 
higher values were obtained after the 12-week training 
on the testing bike ergometers vs. the values before the 
study (1 vs. 3) p < 0.001; 37.34% and before the onset of 
the 12-week interval training (2 vs. 3) p < 0.001; 26.8%. 
Significant differences in Ca levels in serum were 
observed between time point (2) and time point (3). 
Prior to the 12-week physical training, Ca levels were 
significantly higher, when compared with the results 
after the 12-week training on the testing bike ergom-
eters (2 vs. 3) p < 0.01; 3.23% (see Table II).
Based on obtained data, statistically significantly 
higher serum OC concentrations were observed after the 
12-week training period on the testing bike ergometers 
in comparison with OC concentration values before the 
study (1 vs. 3) p < 0.005; 9.09% and before the training 
(2 vs. 3) p < 0.001; 13.05% (see Figure 2). A drop down 
of OC level was noted in six cases after training only. 
No significant differences were obtained in b-CTX 
variable levels at the analysed time points (see Figure 3).
Sclerostin concentrations were significantly lower 
after the 12-week physical training vs. its concentra-
tions before the study (1 vs. 3) p < 0.001; by 12.04% 
and before the training on the testing bike ergometers 
(2 vs. 3) p < 0.001; by 12.44% (see Figure 4). An increase 
of sclerostin concentration was observed in four cases 
after training only.
Table II. Analysis of total vitamin D, alkaline phosphatase, calcium, phosphate, osteocalcin, b-CTX and sclerostin serum 
concentrations in 3 time points of the study
Tabela II. Analiza stężeń witaminy D, fosfatazy zasadowej, wapnia i fosforanów, osteokalcyny, b-CTX oraz sklerostyny 
w surowicy w 3 badanych punktach czasowych badania
(1)
Baseline
(2) after 12 weeks 
without physical 
training 
p level (1 
vs. 2)
(3) after 12 weeks 
of interval physical 
training 
p level (2 
vs. 3)
p level (1 vs. 3)
Mean SD Mean SD Mean SD
Vitamin D [ng/mL] 23.70 11.96 25.67 12.36 p < 0.0001 32.55 10.22 p < 0.001 p < 0.001
ALP [U/L] 75.24 14.85 77.12 16.68 NS 75.95 16.58 NS NS
Ca [mmol/L] 2.43 0.12 2.48 0.10 NS 2.40 0.18 p<0.01 NS
P [mmol/L] 1.14 0.13 1.18 0.11 NS 1.14 0.14 NS NS
Ostecalcin [ng/mL ] 21.67 8.01 20.91 7.25 NS 23.64 8.43 p < 0.001 p < 0.005
b-CTX [ng/mL] 0.40 0.21 0.41 0.19 NS 0.39 0.20 NS NS
Sclerostin [ng/mL] 275.82 38.15 277.07 38.35 NS 242.60 43.04 p < 0.001 p < 0.001
NS — not significant
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Correlations between absolute (differences) and 
relative changes
Because the distributions of absolute and relative dif-
ferences (time points 1 and 3 and time points 2 and 3) 
for OC and sclerostin significantly differed from nor-
mal distribution (p < 0.05 for the Shapiro-Wilk test), 
the Spearman’s rank correlation test was used for the 
analysis of the existing correlations. 
No significant correlations were observed during 
the performed study between the relative changes of 
osteocalcin concentrations at time points 1 and 3 and 
2 and 3 and the corresponding absolute changes of 
sclerostin concentrations between time points 1 and 
3 and 2 and 3, respectively (p > 0.05) (data not shown).
Discussion
Bone metabolic markers may be useful in the diagnosis 
and monitoring of not only osteoporosis [21, 22], but 
may also be applied in other diseases that secondarily 
lead to bone metabolic disorders [23–25]. In our study 
we have assessed the effect of physical activity on 
changes in sclerostin and other known bone metabolism 
markers levels.
Significantly higher values of vitamin D3 were ob-
tained after the 12-week training on the testing bike 
ergometers vs. the values before the study (1 vs. 3; 
p < 0.001) and before the onset of the 12-week inter-
val training (2 vs. 3; p < 0.001). All the patients were 
supplemented with calcium and vitamin D prior to 
enrollment and all of them declared good compliance in 
terms of above supplementation, but it is possible that 
the inclusion of the study led to its further improve-
ment (greater involvement in the therapeutic process) 
and gradual increase of total serum vitamin D level. 
Significantly lower serum Ca levels after training were 
probably associated with higher calcium utilization, 
as well as with changes in electrolyte concentrations 
and acid-base balance. The above changes depends on 
intensity of physical activity and load [26].
Based on obtained data, statistically significantly 
higher serum OC concentrations were observed after 
the 12-week training period on the testing bike ergome-
ters in comparison with OC concentration values before 
the study (p < 0.001). No significant differences were 
obtained in b-CTX variable levels at the analysed time 
points. In a study by Adami et al. [27], similar results 
were obtained, concerning OC and b-CTX concentra-
tion changes after the physical activity programme in 
premenopausal women was over. 
In a study by Pernambuco et al. [28] the influence of 
physical activity (aerobic in water) on BMD and serum 
Figure 2. The changes of osteocalcin concentration for whole 
population in 3 time study points of the study
Rycina 2. Zmiany stężeń osteokalcyny w populacji badanej 
w 3 badanych punktach czasowych
Figure 3. The changes of b-CTX concentration for whole 
population in 3 time study points of the study
Rycina 3. Zmiany stężeń b-CTX w populacji badanej 
w 3 badanych punktach czasowych
Figure 4. The changes of sclerostin concentration for whole 
population in 3 time points of the study
Rycina 4. Zmiany stężeń sklerostyny w populacji badanej 
w 3 badanych punktach czasowych
147
Endokrynologia Polska 2018; 69 (2)
PR
A
C
E 
O
RY
G
IN
A
LN
E
osteocalcin was evaluated, as well as the “stand up and 
go” test in 82 postmenopausal women with low BMD 
values. The patients were randomly divided into two 
groups: the water aerobic group — exercises twice a 
week during 8 months and a control group without 
regular exercises. After the study was over, a significant 
increase in serum OC levels was observed in the group 
of physically active patients, similarly as in our study. 
No statistically significant BMD differences were seen 
between the two groups.
There are relatively few studies about the effects of 
physical training on sclerostin levels [6]. Ardawi et al. [29] 
performed an evaluation of physical activity effects on 
sclerostin and bone turnover marker (BTM) levels in se-
rum and on BMD. Women at the age of 20–49 years, were 
divided into two groups: one group undertaking physi-
cal activity (PA) > 120 minutes 4 times a week (n = 58) 
and a control group < 30 minutes of physical exercises 
a week (n = 62). An 8-week programme of physical 
activity, undertaken by the active group, provided 
decreases in serum sclerostin concentrations (by 33.9%, 
p = 0.0001) and increased serum levels of osteogenesis 
markers. The observed increased values of OC, ALP 
and procollagen type I N-terminal propeptide (PINP) 
were significantly higher in PA group. Thus, the authors 
of above study obtained convergent results to ours. 
Huovinen et al. [30] analyzed the effects of resistance 
training on the elderly patients with reduced muscle 
strength. After 16 weeks of intervention a significant 
increase in sclerostin and OC was noted, unlike the 
other markers (CTX and PINP).
Changes in bone markers levels may also be de-
pendent on the primary BMD and kind of physical 
activity (discipline). In the study of Ahn et al. [31] after 
a 12-week exercise programme a significantly higher 
increase in OC concentration was seen in the group 
of female osteoporotic patients than in a group of 
women with normal BMD. Lombardi et al. [32] showed 
that intensive cycling is associated with a decrease 
in total OC serum concentrations and an increase in 
the percentage of its undercarboxylated fraction. The 
authors emphasized that the results were affected by 
a large individual variability. In another study [33] of 
48 postmenopausal women with low BMD there were 
no differences in the concentrations of CTX and OC 
between the group of patients after a 10-week group-
based step aerobics and the control group. The different 
results were obtained by Mohr et al. [34], who analyzed 
influence of 15 weeks of different forms of training on 
female population. In this study, a significant increase in 
bone resorption (CTX) and formation markers (OC and 
PINP) were obtained only in a subpopulation of women 
training football in comparison to the control group 
and swimming subpopulation, but before drawing 
the conclusions one should remember that these were 
premenopausal women. Study on a similar population 
of Polish women showed no difference between the 
concentrations of OC and CTX between the population 
of equestrians and the control group [35].
Some clinical data suggest that circulating sclerostin 
is associated with BMD in older women and men. 
In one study [36], a significant negative correlation 
was demonstrated between serum sclerostin and OC 
concentrations and BMD. By contrast, no correlation 
was observed in our study between sclerostin and OC 
concentration changes. It should be emphasised that 
the first 12 weeks in our study provided a control group 
for the later training cycle and the BMD evaluation was 
done for qualification at the moment, when the patients 
were included into the study, thus it is not possible to 
determine BMD changes. In several studies by other 
authors, higher BMD was demonstrated in groups of 
exercising women. Bergstrom et al. [37] analyzed BMD 
and BTM changes in a group of patients undertaking 
motor activity for 12 weeks (30-minute marches three 
times a week and one 1-hour aerobic training). After 
the training programme was over, a significant BMD 
increase was demonstrated in the femoral neck. CTX 
and ALP, bone turnover markers, revealed a slightly 
falling (insignificant) tendency in comparison to the 
control group. 
A statistically significant BMD rise in the lumbar 
spine and in the neck was also achieved in a study of 
Gaudio et al. [38] after the physical activity. Addition-
ally, a significant serum sclerostin increase was dem-
onstrated in a group of immobilised postmenopausal 
female patients vs. a control group — physically active 
women — (p < 0.0001) — with higher bone turnover 
and prevalence of CTX vs. ALP. In the immobilised 
group, a negative correlations between sclerostin and 
ALP (r = –0.911; p < 0.0001) was observed and posi-
tive correlation with CTX (r = 0.391, p = 0.012). Those 
observations emphasise the important role of physical 
activity in bone formation processes [38]. 
The literature reports on the sclerostin serum levels 
in athletes compared with non-active individuals are 
frequently inconclusive and call into question whether 
small differences in sclerostin levels are of physiologic 
or clinical significance. Gombos et al. [6] found that 
sclerostin levels increased in a similar group of women 
as in our study, who underwent a program of walking 
exercise or resistance exercise, compared to a control 
group. Similar results were presented by Zagrodna 
et al. [39] who reported that male athletes had sig-
nificantly higher sclerostin levels than age-matched 
sedentary men. Also, Lombardi et al. [40] investigating 
sclerostin concentrations in elite athletes, found higher 
sclerostin levels in males participating in weight-bearing 
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disciplines than in those who participated in non-
weight-bearing sports. It can be assumed that different 
types of physical activity result in differences in scle-
rostin levels. Moreover, Lombardi et al. [40], unlike to 
us, showed that individuals with low levels of physical 
activity have lower serum concentrations of sclerostin 
than professional rugby players or endurance athletes.
At present, the prophylactics of osteoporotic frac-
tures is mainly based on pharmacotherapy which 
has proven effective in reducing fracture risks [41]. 
However, high doses of bisphosphonates, despite 
BMD improvement, may lead to accumulation of 
micro traumas and decreased ability to absorb energy 
by the trabecular bone, what may paradoxically lead 
to higher fracture risks [41]. Contrary to the therapy 
with medicinal agents, mechanical loads, achieved 
by properly targeted physical exercise, may lead to 
a considerable improvement of such properties as 
mechanical strength — i.e., the force level necessary 
to cause bone fracture. Still, physical exercises should 
never replace pharmacological therapy of osteoporo-
sis, while — when properly planned — they improve 
a number of features and properties, regardless of BMD, 
including the sense of balance, gait mechanics, agility, 
muscular strength, resistance to fatigue, where none of 
the features depends on bisphosphonate therapy [41]. 
One of the limitations in our study was the neces-
sity to participate in each training session, 3 times 
a week for 12 weeks, which was unacceptable by some 
of our patients. We are also aware of the small size of 
our population. Our knowledge of the relationships 
between specific forms of physical effort and bone 
formation processes is rather limited. In the above 
described studies physical activity was evaluated in 
non-uniform ways and the studied populations differed 
significantly from each other. Based on reported study, 
an adopted programme of physical activity seems to be 
an effective way to stimulate osteogenesis processes in 
female patients with low bone mass.
Muscular contractions stimulate the formation pro-
cesses of bones on their surface (periosteum), leading to 
an increased resistance to bending forces. It may then be 
more important than the BMD increase itself. Periosteal 
increase may falsify the actual effects on BMD, as it 
increases bone cross-section area, consequently increas-
ing the denominator, used to calculate bone mineral 
density (i.e., bone mineral content/studied area). The 
example comes from studies on osteoporotic fractures 
[42] in which, women achieved higher body mass by 
increased bone strength, while reducing femoral bone 
BMD values. Therefore, the value of exercises in os-
teoporosis prophylactics and therapy cannot be fully 
evaluated by their effects on BMD [42]. 
Summing up, the 12-week interval training on cycle 
ergometer bikes increased serum OC, while decreasing 
serum sclerostin concentrations. The bone turnover 
markers may be helpful in the evaluation of the efficacy 
of carried out physical activity, but we are aware that 
they have some limitations. OC plays also role in energy 
metabolism, e.g. physical activity (energy expenditure) 
and the changes of its concentrations could be partially 
independent of bone formation. Sclerostin concentra-
tion fall after properly planned physical training may 
play a significant function of osteoblastogenesis stimula-
tor, and its serum concentrations may be considered as 
a potentially valuable parameter in the monitoring and 
forecasting of further therapy course, while strength 
training may be perceived as a multidirectional way 
of therapy in cases of osteopenia and postmenopausal 
osteoporosis. 
Conclusions
The obtained results emphasise the role of physical 
activity as an effective stimulation method of bone 
formation processes in female patients with low bone 
mass, with many combined advantages for patient 
health. Sclerostin can be a marker of physical activity.
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